Brandon Poe - 11 Nov 2026 Form 4 Insider Report for BioStem Technologies, Inc. (BSEM)

SEC form
4
Accepted by SEC
13 Nov 2026, 16:30:17 UTC
Prior SEC filing
17 Sep 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Brandon Poe filed Form 4 for BioStem Technologies, Inc. (BSEM) on 13 Nov 2026.

Key facts

  • This page summarizes Brandon Poe's Form 4 filing for BioStem Technologies, Inc. (BSEM).
  • 2 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 13 Nov 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 17 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002147189 Primary reporting owner

POE BRANDON

Relationship
Chief Financial Officer

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSEM transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,699
Change %
+4.6%
Price
$0.000000*
Shares after
60,763
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSEM transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-2,699
Change %
-13%
Price
$0.000000*
Shares after
18,892
Date
11 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,699
Exercise price
Footnotes
F4, F6
BSEM holding Derivative

Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
38,814
Date
11 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
38,814
Exercise price
$6.48
Footnotes
F2
BSEM holding Derivative

Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
117,401
Date
11 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
117,401
Exercise price
$5.50
Footnotes
F3
BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,773
Date
11 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,773
Exercise price
Footnotes
F1, F4, F5
BSEM holding Derivative

Restricted Stock Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
96,909
Date
11 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
96,909
Exercise price
Footnotes
F4, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Reflects an adjustment to total holdings to include two shares incorrectly excluded in prior reports.

Footnote F2

These options vest according to the following schedule: 33% vested on August 11, 2026, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F3

These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Footnote F5

These restricted stock units vest in equal quarterly installments over three year from the grant date (September 15, 2024).

Footnote F6

These restricted stock units vest according to the following schedule: 33% vested on August 11, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period.

Footnote F7

These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .